Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark.

Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC.

BMJ. 2013 Jan 8;346:e8441. doi: 10.1136/bmj.e8441.

2.

Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.

Heresbach D, Manfredi S, D'halluin PN, Bretagne JF, Branger B.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):427-33. Review.

PMID:
16538116
3.

The benefits and harms of breast cancer screening: an independent review.

Independent UK Panel on Breast Cancer Screening.

Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30. Review.

PMID:
23117178
4.

Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.

Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L.

Ann Intern Med. 2016 Feb 16;164(4):244-55. doi: 10.7326/M15-0969. Epub 2016 Jan 12. Review.

PMID:
26756588
5.

Screening for colorectal cancer using the faecal occult blood test, hemoccult.

Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J.

Cochrane Database Syst Rev. 2000;(2):CD001216. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD001216.

PMID:
10796760
6.

Benefits and Harms of Breast Cancer Screening: A Systematic Review.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD.

JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. Review. Erratum in: JAMA. 2016 Apr 5;315(13):1406.

7.

Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.

Ringash J; Canadian Task Force on Preventive Health Care.

CMAJ. 2001 Feb 20;164(4):469-76. Review. Erratum in: CMAJ 2001 Mar 20;164(6):753.

8.

Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.

Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L.

Ann Intern Med. 2016 Feb 16;164(4):256-67. doi: 10.7326/M15-0970. Epub 2016 Jan 12. Review.

PMID:
26756737
9.

Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force.

Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42. doi: 10.7326/0003-4819-151-10-200911170-00009. Review.

10.

Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians.

Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE.

Ann Intern Med. 2007 Apr 3;146(7):516-26. Review.

PMID:
17404354
11.

The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.

Robertson C, Arcot Ragupathy SK, Boachie C, Dixon JM, Fraser C, Hernández R, Heys S, Jack W, Kerr GR, Lawrence G, MacLennan G, Maxwell A, McGregor J, Mowatt G, Pinder S, Ternent L, Thomas RE, Vale L, Wilson R, Zhu S, Gilbert FJ.

Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322. doi: 10.3310/hta15340. Review.

12.

Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening.

Autier P, Héry C, Haukka J, Boniol M, Byrnes G.

J Clin Oncol. 2009 Dec 10;27(35):5919-23. doi: 10.1200/JCO.2009.22.7041. Epub 2009 Nov 2. Review.

PMID:
19884547
13.

Screening for early colorectal cancer.

Kronborg O.

World J Surg. 2000 Sep;24(9):1069-74. Review.

PMID:
11036284
14.

Mammographic screening: evidence from randomised controlled trials.

de Koning HJ.

Ann Oncol. 2003 Aug;14(8):1185-9. Review.

PMID:
12881373
15.

[Examples of screening investigations].

Eickhoff A, Hahn A, Riemann JF.

Internist (Berl). 2008 Jun;49(6):660, 662-4, 666-8, 670-2. doi: 10.1007/s00108-008-2163-3. Review. German.

PMID:
18461294
16.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
17.

Mammography in symptomatic and asymptomatic patients.

Stomper PC, Gelman RS.

Hematol Oncol Clin North Am. 1989 Dec;3(4):611-40. Review.

PMID:
2691492
18.

Screening for breast cancer with mammography.

Gøtzsche PC, Jørgensen KJ.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Review.

19.

Screening for breast cancer with mammography.

Gøtzsche PC, Nielsen M.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001877. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD001877.

PMID:
17054145
20.

Statistical analyses in Swedish randomised trials on mammography screening and in other randomised trials on cancer screening: a systematic review.

Autier P, Boniol M, Smans M, Sullivan R, Boyle P.

J R Soc Med. 2015 Nov;108(11):440-50. doi: 10.1177/0141076815593403. Epub 2015 Jul 7. Review.

Supplemental Content

Support Center